MAZE THERAPEUTICS INC (MAZE) Stock Analyst Ratings
USA - NASDAQ:MAZE - US5787841007 - Common Stock
32.53 USD
+0.69 (+2.17%)
32.53 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 87% to MAZE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 38.76. This target is 19.15% above the current price.
MAZE was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about MAZE.
In the previous month the buy percentage consensus was at a similar level.
MAZE was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-15 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-12 | BTIG | Maintains | Buy -> Buy |
| 2025-09-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-11 | BTIG | Maintains | Buy -> Buy |
| 2025-09-02 | BTIG | Initiate | Buy |
| 2025-07-23 | HC Wainwright & Co. | Initiate | Buy |
| 2025-07-08 | Wedbush | Initiate | Outperform |
| 2025-04-02 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-25 | Leerink Partners | Initiate | Outperform |
| 2025-02-25 | Guggenheim | Initiate | Buy |
| 2025-02-25 | JP Morgan | Initiate | Overweight |
MAZE THERAPEUTICS INC / MAZE FAQ
What is the price target for MAZE stock?
12 analysts have analysed MAZE and the average price target is 38.76 USD. This implies a price increase of 19.15% is expected in the next year compared to the current price of 32.53.
Can you provide the consensus rating for MAZE THERAPEUTICS INC stock?
The consensus rating for MAZE THERAPEUTICS INC (MAZE) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for MAZE THERAPEUTICS INC stock?
The number of analysts covering MAZE THERAPEUTICS INC (MAZE) is 12.